YOSHIO INOUE M.D. NPI 1891748331

NPI Details

Yoshio Inoue, M.D. is a medical oncology internal medicine in Everett, WA with 23 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Yoshio Inoue, M.D. NPI is 1891748331. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Graduation Year:2003

The provider's business location address is:

1717 13TH ST
EVERETT, WA
ZIP 98201-621
Phone: (425) 297-5571

The NPI 1891748331 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, gadoterate meglumine, 0.1 ml (HCPCS:A9575)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ct scan of chest with contrast (HCPCS:71260)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood creatinine level (HCPCS:82565)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Unclassified drugs (HCPCS:J3490)
• Folic acid level, serum (HCPCS:82746)
• Ct scan of chest without contrast (HCPCS:71250)

The enumeration date for this NPI number is 5/18/2006 and was last updated on 7/31/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.